RecallDepth
Class II Terminated

Atracurium Besylate Injection, USP, 50 mg per 5 mL (10 mg per mL), Rx Only, 5 mL Single-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-659-05

Company
Sagent Pharmaceuticals Inc
Recall Initiated
February 23, 2015
Posted
March 11, 2015
Recall Number
D-0398-2015
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
140,720 vials
Firm Location
Schaumburg, IL, United States

Reason for Recall

Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot Numbers: VATA012, Exp 11/15; VATA015, Exp 08/16

More recalls by Sagent Pharmaceuticals Inc

View all recalls by this company →

Other recent Class II Drug recalls